View in EDS

Review of Survival, Safety, and Clinical Outcomes in HER2+ Metastatic Gastric Cancer Following the Administration of Trastuzumab.

Saved in:
Bibliographic Details
Title: Review of Survival, Safety, and Clinical Outcomes in HER2+ Metastatic Gastric Cancer Following the Administration of Trastuzumab.
Authors: Hackshaw MD; Department of Medical Affairs for Global Medical Affairs, Daiichi Sankyo, Basking Ridge, NJ, USA., Bui CL; Department of Epidemiology, RTI Health Solutions, Research Triangle Park, NC, USA., Ladner A; Department of Epidemiology, RTI Health Solutions, Research Triangle Park, NC, USA., Tu N; Department of Epidemiology, Clinical Safety and Pharmacovigilance, Daiichi Sankyo, Basking Ridge, NJ, USA., Islam Z; Department of Epidemiology, Clinical Safety and Pharmacovigilance, Daiichi Sankyo, Basking Ridge, NJ, USA., Ritchey ME; Department of Epidemiology, RTI Health Solutions, Research Triangle Park, NC, USA., Salas M; Department of Epidemiology, Clinical Safety and Pharmacovigilance, Daiichi Sankyo, Basking Ridge, NJ, USA; CCEB/CPeRT, University of Pennsylvania Perelman School of Medicine, Philadelphia, USA. Electronic address: msalas@dsi.com.
Source: Cancer treatment and research communications [Cancer Treat Res Commun] 2020; Vol. 24, pp. 100189. Date of Electronic Publication: 2020 Jun 30.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101694651 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2468-2942 (Electronic) Linking ISSN: 24682942 NLM ISO Abbreviation: Cancer Treat Res Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2468-2942
DOI:10.1016/j.ctarc.2020.100189